News for Brainstorm Cell Therapeutics Inc. (BCLI)

Transaction Overview On December 31, 2024, ARMISTICE CAPITAL, LLC (Trades, Portfolio) executed a significant transaction involving Brainstorm Cell Therapeutics

PR NewswireNEW YORK, Dec. 9, 2024 Call Scheduled for December 30, 2024, at 8:30 AM ET; Additionally, Key Opinion Leader Webinar on ALS Advancements to Take

PR NewswireNEW YORK, Dec. 3, 2024 NEW YORK, Dec. 3, 2024 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult ste

PR NewswireNEW YORK, Dec. 2, 2024 NEW YORK, Dec. 2, 2024 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult ste

BrainStorm regains Nasdaq compliance with bid price rule

BCLI stock touches 52-week low at $1.95 amid market challenges

BCLI stock touches 52-week low at $1.97 amid market challenges

BrainStorm Cell Therapeutics to Provide Corporate Update on Phase 3b NurOwn ® Trial at the 2024 Maxim Healthcare Virtual Summit

U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.41%

BrainStorm announces reverse stock split

The market growth rate is significantly impacted by the rising prevalence of motor neuron disease and the increasing geriatric population. Additionally,...

Shares of Biophytis S.A. (NASDAQ: BPTS) rose sharply in today’s pre-market trading after reporting FY23 results.

Shares of Landos Biopharma, Inc. (NASDAQ: LABP) rose sharply during Monday’s session following acquisition news.

Shares of Ascent Industries Co. (NASDAQ: ACNT) rose sharply in pre-market trading as the company reported the sale of the business of Specialty Pipe & Tube for around $55 million in an all-cash deal. Ascent Industries shares surged 7.4% to $8.69 in pre-market trading.

Gainers

/PRNewswire/ -- The cell therapy market size is expected to grow by USD 31.04 billion from 2022 to 2027. In addition, the momentum of the market will progress...

Gainers Gaucho Group Holdings, Inc. (NASDAQ: VINO) jumped 95.2% to $3.7280. Gaucho Group is planning to list two of its retail properties in Argentina, in San Rafael and Cordoba, for sale, priced at $2 million and $0.7 million respectively.

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining 1% on Thursday. The Dow traded up 0.58% to 33,745.23 while the NASDAQ rose 1% to 13,223.61. The S&P 500 also rose, gaining, 0.81% to 4,309.27.

Gainers TransCode Therapeutics, Inc. (NASDAQ: RNAZ) shares jumped 308% to $2.71 after the company announced pre-clinical gliblastoma results with its lead candidate, TTX-MC138.